Log in

OCEA Ocean Biomediacal, Inc. OTC · United States

Ocean Biomediacal (OCEA) news OCEA delisting news

Latest Ocean Biomediacal news

  1. Listings

    Ocean Biomedical's Nasdaq delisting becomes final after board declines review

    Nasdaq's board declined to review a May 15, 2025 Listing Council decision, making it Nasdaq's final action. The company's chief financial officer and a director have also resigned.

Ocean Biomediacal annual financials

LineFY2024FY2023
Research and development$26,000$709,000
Net income (loss)-$9.5 million-$114.5 million
Cash from operations-$4.2 million-$9.4 million
Cash and equivalents$200,000$1.0 million

Latest balance sheet, Mar 31, 2025 (10-Q): cash and equivalents $800,000.

Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice.

Questions about Ocean Biomediacal

Was Ocean Biomediacal delisted?

Our latest story on this, dated Aug 5, 2025: "Ocean Biomedical's Nasdaq delisting becomes final after board declines review". The story links the filing or release it is based on. Read the story.

What is the ticker symbol of Ocean Biomediacal?

Ocean Biomediacal, Inc. trades under the ticker OCEA on OTC.

Where is Ocean Biomediacal listed?

Ocean Biomediacal, Inc. is listed on OTC.

What is the SEC CIK of Ocean Biomediacal?

The SEC Central Index Key (CIK) for Ocean Biomediacal, Inc. is 1869974. Its filings are on SEC EDGAR.

How many shares does Ocean Biomediacal have outstanding?

232,365,143 shares as of 2025-05-15, per the cover page of its 10-Q filed 2025-05-15.

Which country or territory is Ocean Biomediacal listed under?

Our directory records Ocean Biomediacal, Inc. under United States.

What does Ocean Biomediacal do?

Our directory classifies Ocean Biomediacal, Inc. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of Ocean Biomediacal?

The ISIN recorded for Ocean Biomediacal, Inc. is US67644C1045.

Does aibio.space cover Ocean Biomediacal?

aibio.space lists Ocean Biomediacal, Inc. among 2,820 public biotech companies and publishes its news here as stories appear.

Where is Ocean Biomediacal incorporated?

SEC records list its state or country of incorporation as DE.

Is Ocean Biomediacal profitable?

Ocean Biomediacal, Inc. reported a net loss of $9.5 million for the fiscal year ended Dec 31, 2024, and used $4.2 million of cash in operations, per its annual report to the SEC.

How much does Ocean Biomediacal spend on research and development?

$26,000 in the fiscal year ended Dec 31, 2024, per its annual report.

How much cash does Ocean Biomediacal have?

$800,000 in cash at Mar 31, 2025, per its 10-Q.

What is the latest Ocean Biomediacal (OCEA) stock news?

Our latest story on Ocean Biomediacal, dated Aug 14, 2025: "Ocean Biomedical delays quarterly report for period ended June 30, 2025". The company said it is working with its auditor to finish the review of its Form 10-Q. It expects to file within 5 calendar days of the due date. Source.

Is Ocean Biomediacal in financial distress?

Our latest distress story, dated Aug 14, 2025: "Ocean Biomedical delays quarterly report for period ended June 30, 2025". The company said it is working with its auditor to finish the review of its Form 10-Q. It expects to file within 5 calendar days of the due date. Source.

Investor discussion: Ocean Biomediacal

Members talk about Ocean Biomediacal (OCEA). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Capital-markets timeline

Financings, listing notices, splits, legal actions and other investor events at Ocean Biomediacal, newest first. Each line links the filing it comes from.

  1. Distress

    Told the SEC a periodic report would be filed late. SEC Form NT 10-Q. Source

  2. Listings

    Filed to remove its shares from exchange listing. SEC Form 25-NSE. Source

  3. Listings

    Reported a notice from its stock exchange about continued listing requirements. SEC Form 8-K (Items 3.01,5.02,8.01). Source

  4. Listings

    Reported a notice from its stock exchange about continued listing requirements. SEC Form 8-K (Items 3.01). Source

  5. Distress

    Reported the end of a material agreement. SEC Form 8-K (Items 1.02). Source

  6. Distress

    Reported the end of a material agreement. SEC Form 8-K (Items 1.02). Source

  7. Listings

    Reported a notice from its stock exchange about continued listing requirements. SEC Form 8-K (Items 3.01,5.02,8.01,9.01). Source

  8. Distress

    Told the SEC a periodic report would be filed late. SEC Form NT 10-K. Source

  9. Listings

    Reported a shareholder vote on a reverse stock split or more authorized shares. SEC Form 8-K (Items 5.07). Source

  10. Listings

    Reported a notice from its stock exchange about continued listing requirements. SEC Form 8-K (Items 3.01). Source

  11. Listings

    Asked shareholders to approve a reverse stock split. SEC Form DEF 14A. Source

  12. Listings

    Reported a reverse stock split. SEC Form 8-K (Items 3.02,5.03,9.01). Source

  13. Listings

    Asked shareholders to approve a reverse stock split. SEC Form PRE 14A. Source

  14. Financings

    Reported an unregistered sale of its securities. SEC Form 8-K (Items 3.02,8.01). Source

  15. Listings

    Reported a notice from its stock exchange about continued listing requirements. SEC Form 8-K (Items 3.01). Source

  16. Legal

    Reported a change of independent auditor. SEC Form 8-K (Items 4.01). Source

  17. Listings

    Reported a notice from its stock exchange about continued listing requirements. SEC Form 8-K (Items 3.01). Source

  18. Legal

    Reported a change of independent auditor. SEC Form 8-K (Items 4.01,9.01). Source

  19. Listings

    Reported a notice from its stock exchange about continued listing requirements. SEC Form 8-K (Items 3.01,7.01,9.01). Source

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open OTC:OCEA on TradingView.

SEC filings and registration

SEC name
Ocean Biomedical, Inc.
CIK
1869974
Industry (SIC)
Pharmaceutical Preparations (2834)
US tickers
OCEA (OTC)
State or country of incorporation
DE
Fiscal year ends
December 31
Filer category
<br>Emerging growth company
Business address
515 MADISON AVE SUITE 8078, NEW YORK, NY, 10022
Phone
(646) 908-2658
Shares outstanding
232,365,143 as of 2025-05-15 (10-Q filed 2025-05-15)
Former names
Ocean Biomedical, Inc./DE; Aesther Healthcare Acquisition Corp.

Recent filings (8-K and 6-K are the company's own announcements)

  • 8-K filed 2025-08-05
  • 8-K filed 2025-07-23
  • 8-K filed 2025-07-16
  • 8-K filed 2025-06-13
  • 10-Q filed 2025-05-15
  • 8-K filed 2025-04-23
  • 10-K filed 2025-04-08
  • 8-K filed 2025-04-01

Source: SEC EDGAR, retrieved October 23, 2026. Shares outstanding is the cover-page figure from the latest periodic report. The SEC does not publish share prices.

Listing details

Ocean Biomediacal, Inc. is a public biotech or pharmaceutical company listed on OTC under the ticker OCEA, recorded under United States. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Ocean Biomediacal, Inc.
Ticker
OCEA
Listing
OTC
Country or territory
United States
Business scope
Pharmaceuticals: Major
ISIN
US67644C1045
Last quote in directory
2026-10-20
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.